TERMINATED

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Official Title

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Quick Facts

Study Start:2023-07-20
Study Completion:2024-04-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT05819619

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 50 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Healthy
  2. * English speaking
  3. * female volunteers undergoing medical abortion whether for voluntary interruption of pregnancy or missed abortion
  4. * Gestational age \</= 70 days confirmed via ultrasound
  5. * Access to a time keeping device
  6. * Willingness to complete a telephone or in-clinic follow up
  1. * chronic medical problems including but not limited to cardiac conditions, malignancy or organ damage
  2. * Failed medical abortion resulting in surgical management
  3. * Known intrauterine infection
  4. * Known allergy to ondansetron or ibuprofen
  5. * Subjects chronically receiving analgesic drugs
  6. * Subjects unable to give consent
  7. * Subjects taking medications that interact with ondansetron or ibuprofen

Contacts and Locations

Principal Investigator

Melissa Figueroa, MD
PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health

Study Locations (Sites)

Antonia Oladipo
Hackensack, New Jersey, 07601
United States

Collaborators and Investigators

Sponsor: Hackensack Meridian Health

  • Melissa Figueroa, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-20
Study Completion Date2024-04-11

Study Record Updates

Study Start Date2023-07-20
Study Completion Date2024-04-11

Terms related to this study

Keywords Provided by Researchers

  • medical abortion
  • prophylactic use
  • nausea
  • pain
  • patient satisfaction

Additional Relevant MeSH Terms

  • Nausea
  • Pain